Double maintains 3 strategies that include APLS - Apellis Pharmaceuticals, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ROIV | 45.66% | $7.67B | +4.16% | 0.00% |
BPMC | 44.20% | $8.27B | +20.55% | 0.00% |
KYMR | 42.49% | $3.15B | +39.86% | 0.00% |
ARWR | 41.80% | $2.31B | -35.04% | 0.00% |
DNLI | 41.78% | $2.21B | -29.48% | 0.00% |
RARE | 41.69% | $3.55B | -15.97% | 0.00% |
DAWN | 41.63% | $684.19M | -48.08% | 0.00% |
EYPT | 41.60% | $606.23M | -5.47% | 0.00% |
BEAM | 41.42% | $1.80B | -31.35% | 0.00% |
IMVT | 40.43% | $2.76B | -36.82% | 0.00% |
COGT | 40.14% | $826.59M | -19.69% | 0.00% |
NTLA | 40.12% | $866.99M | -67.62% | 0.00% |
IMNM | 38.94% | $825.75M | -40.69% | 0.00% |
CRSP | 38.77% | $3.59B | -35.96% | 0.00% |
VTYX | 38.72% | $173.63M | -18.12% | 0.00% |
ELVN | 38.18% | $962.00M | -13.82% | 0.00% |
KALV | 38.15% | $669.17M | +8.99% | 0.00% |
PAX | 38.02% | $2.21B | +10.09% | 4.37% |
CLDX | 37.85% | $1.36B | -43.29% | 0.00% |
ZYME | 37.76% | $904.86M | +37.61% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -31.66% | $297.88M | 1.43% |
VIXY | -31.19% | $178.15M | 0.85% |
TAIL | -28.53% | $107.71M | 0.59% |
ULST | -13.89% | $667.10M | 0.2% |
CLIP | -13.83% | $1.50B | 0.07% |
USDU | -12.84% | $166.08M | 0.5% |
IVOL | -10.62% | $357.32M | 1.02% |
XHLF | -9.96% | $1.64B | 0.03% |
LDUR | -9.62% | $913.92M | 0.5% |
XONE | -8.66% | $639.23M | 0.03% |
UUP | -7.49% | $200.21M | 0.77% |
TPMN | -7.20% | $30.69M | 0.65% |
GBIL | -7.19% | $6.05B | 0.12% |
FTSD | -6.86% | $228.22M | 0.25% |
SPTS | -6.78% | $5.78B | 0.03% |
BILZ | -6.04% | $840.07M | 0.14% |
BUXX | -5.98% | $309.14M | 0.25% |
UTWO | -5.97% | $374.45M | 0.15% |
TBIL | -5.59% | $5.91B | 0.15% |
SHYM | -4.54% | $324.00M | 0.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -11.20% | $21.77M | -74.81% | 0.00% |
K | -10.31% | $28.31B | +38.89% | 2.82% |
CORT | -9.52% | $7.55B | +118.26% | 0.00% |
VSA | -9.29% | $8.67M | -17.07% | 0.00% |
FMTO | -8.14% | $5.10K | -99.92% | 0.00% |
MCK | -6.67% | $89.80B | +22.74% | 0.39% |
FATBB | -6.62% | $43.80M | -23.18% | 10.33% |
ED | -6.41% | $36.95B | +12.52% | 3.26% |
MO | -6.38% | $100.92B | +30.61% | 6.82% |
PULM | -5.71% | $30.39M | +340.19% | 0.00% |
RPRX | -5.55% | $14.35B | +25.18% | 2.46% |
HUSA | -5.32% | $8.56M | -56.67% | 0.00% |
CBOE | -4.53% | $23.34B | +31.58% | 1.12% |
AEP | -4.27% | $54.46B | +15.89% | 3.59% |
NEUE | -3.79% | $60.80M | +26.11% | 0.00% |
EXC | -3.44% | $43.29B | +23.40% | 3.60% |
CYCN | -3.25% | $9.66M | +32.60% | 0.00% |
PPC | -2.71% | $10.70B | +45.42% | 0.00% |
CCEC | -2.61% | $1.02B | +3.91% | 2.79% |
CEG | -1.39% | $91.58B | +33.95% | 0.49% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TDTT | -<0.01% | $2.58B | 0.18% |
KCCA | 0.03% | $98.85M | 0.87% |
SHY | 0.04% | $23.87B | 0.15% |
FTSM | 0.06% | $6.44B | 0.45% |
JMST | -0.06% | $3.92B | 0.18% |
FXY | 0.29% | $855.96M | 0.4% |
SGOV | 0.30% | $48.67B | 0.09% |
VTIP | 0.30% | $15.09B | 0.03% |
DBE | 0.40% | $48.63M | 0.77% |
CTA | -0.44% | $1.09B | 0.76% |
MLN | 0.46% | $523.51M | 0.24% |
SOYB | -0.47% | $25.65M | 0.22% |
SHV | -0.51% | $20.33B | 0.15% |
BIL | 0.58% | $44.06B | 0.1356% |
BNO | 0.59% | $87.48M | 1% |
UGA | 0.64% | $72.33M | 0.97% |
IBDQ | -0.68% | $3.04B | 0.1% |
IEI | 0.72% | $15.22B | 0.15% |
SCHO | -0.73% | $10.89B | 0.03% |
STOT | -0.76% | $236.01M | 0.45% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 53.55% | $4.99B | 0.35% |
GNOM | 49.88% | $44.85M | 0.5% |
IBB | 49.82% | $5.26B | 0.45% |
ARKG | 44.89% | $977.20M | 0.75% |
PBE | 44.88% | $228.06M | 0.58% |
IWO | 43.00% | $11.49B | 0.24% |
BBH | 41.90% | $338.76M | 0.35% |
PAWZ | 41.85% | $64.09M | 0.5% |
IWC | 41.83% | $815.56M | 0.6% |
IWM | 41.68% | $63.71B | 0.19% |
VTWO | 41.47% | $12.43B | 0.07% |
KJUL | 40.62% | $120.33M | 0.79% |
KJAN | 39.89% | $289.02M | 0.79% |
QQQJ | 39.84% | $615.50M | 0.15% |
SCHA | 39.57% | $17.18B | 0.04% |
VBK | 39.33% | $18.73B | 0.07% |
KOMP | 39.15% | $2.25B | 0.2% |
PTH | 39.04% | $105.01M | 0.6% |
ISCG | 38.84% | $674.42M | 0.06% |
IWN | 38.80% | $11.10B | 0.24% |
Yahoo
Kodiak Sciences (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Finnhub
Presenter SpeechSalveen Richter Good morning, everyone. Thank you so much for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs, and we're really pleased to have with us today...
SeekingAlpha
During Q1 2025, the Harbor Long-Short Equity ETF returned 5.23% (NAV), outperforming its benchmark, the HRFX Equity Hedge Index, which returned 0.22%.
Yahoo
The study aims to assess pegcetacoplan in 124 subjects who are aged 12 years and above.
Finnhub
Sobi and Apellis Pharmaceuticals, Inc. presented new data from the open-label period of the Phase 3 VALIANT study, investigating Aspaveli for C3 glomerulopathy and primary immune complex...
Yahoo
Apellis Pharmaceuticals (APLS) and Sobi (BIOVF) presented new data from the open-label period of the Phase 3 VALIANT study, investigating EMPAVELI for C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis. The data were presented as part of a late-breaking session at the European Renal Association Congress. In the VALIANT study, EMPAVELI demonstrated a statistically significant 68% proteinuria reduction versus placebo at Week 26, which was sustained at one year. A
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BULL | -0.07% | $5.04B | -1.71% | 0.00% |
COR | -0.33% | $55.56B | +24.55% | 0.74% |
IMNN | 0.37% | $29.12M | +36.07% | 0.00% |
ZCMD | -0.37% | $26.26M | -13.33% | 0.00% |
LFVN | -0.39% | $159.24M | +69.34% | 1.30% |
STG | -0.50% | $32.24M | -0.16% | 0.00% |
CHD | 0.52% | $24.41B | -6.85% | 1.17% |
CHRW | 0.55% | $11.23B | +11.55% | 2.62% |
OCFT | -0.55% | $263.44M | +287.03% | 0.00% |
T | 0.58% | $203.92B | +60.93% | 3.93% |
VSTA | 0.65% | $331.23M | +31.32% | 0.00% |
ANGI | -0.75% | $798.02M | -21.18% | 0.00% |
LMT | 0.92% | $106.98B | -0.55% | 2.80% |
CARV | 0.92% | $8.38M | -11.35% | 0.00% |
PRA | 1.25% | $1.18B | +78.48% | 0.00% |
KR | -1.29% | $43.03B | +28.80% | 1.97% |
DFDV | 1.34% | $380.05M | +2,345.35% | 0.00% |
CME | 1.35% | $97.17B | +37.77% | 3.95% |
ARLP | 1.37% | $3.33B | +8.48% | 10.85% |
FROG | 1.37% | $4.81B | +22.33% | 0.00% |
Current Value
$19.011 Year Return
Current Value
$19.011 Year Return